References
- BrunnerHRMenardJWaeberBTreating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinationsJ Hypertens199083112157754
- ChobanianAVBakrisGLBlackHRSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension20034212065214656957
- DusingRAdverse events, compliance, and changes in therapyCurrent Hypertens Rep2001348892
- DusingROvercoming barriers to effective blood pressure control in patients with hypertensionCurr Med Res Opin20062215455316870079
- ElliottWJIs fixed combination therapy appropriate for initial hypertension treatment?Current Hypertens Rep2002427885
- HughesDMcGuireAThe direct costs to the NHS of discontinuing and switching prescriptions for hypertensionJ Hum Hypertens19981253379759987
- JuliusSKjeldsenSEWeberMOutcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialLancet200436320223115207952
- LaurentSClinical benefit of very-low-dose perindopril-indapamide combination in hypertensionJ Hypertens200119suppl 4S9S14
- LawMRWaldNJMorrisJKValue of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trialsBMJ200332614273112829555
- ManciaGDe BackerGDominiczakAGuidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20072511058717563527
- MouradJJWaeberBZannadFComparison of different therapeutic strategies in hypertension: a low-dose combination of perin-dopril/indapamide versus a sequential monotherapy or a stepped-care approachJ Hypertens20042223798615614033
- StaessenJAWangJGThijsLCardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003J Hypertens20032110557612777939
- TurnbullFNealBAlgertCEffects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trialsArch Intern Med200516514101915983291
- UrquhartJSome economic consequences of noncomplianceCurrent Hypertens Rep2001347380
- Van WijkBLKlungelOHHeerdinkERRate and determinants of 10-year persistence with antihypertensive drugsJ Hypertens2005232101716208154
- WelshLFerroADrug treatment of essential hypertension: the case for initial combination therapyInt J Clin Pract2004589566315587775
- WilliamsBRecent hypertension trials: implications and controversiesJ Am Coll Cardiol2005458132715766813
- ZanchettiAEvidence-based medicine in hypertension: what type of evidence?J Hypertens20052311132015894883